{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:24:58Z","timestamp":1761060298487},"reference-count":1,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"15","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2017,5,20]]},"DOI":"10.1200\/jco.2016.72.0011","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T17:11:27Z","timestamp":1487869887000},"page":"1744-1745","update-policy":"http:\/\/dx.doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Role of Cost-Sharing Subsidies on the Initiation of and Adherence to Tyrosine Kinase Inhibitor Therapy by Medicare Beneficiaries With Chronic Myeloid Leukemia"],"prefix":"10.1200","volume":"35","author":[{"given":"Ellen K.","family":"Ritchie","sequence":"first","affiliation":[{"name":"Ellen K. Ritchie, Cornell University and New York Presbyterian Hospital, New York, NY; Annie Guerin, Analysis Group, Inc., Montreal, Quebec, Canada; and Johannes Wolff and George Joseph, Novartis Pharmaceuticals Corp., East Hanover, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Guerin","sequence":"additional","affiliation":[{"name":"Ellen K. Ritchie, Cornell University and New York Presbyterian Hospital, New York, NY; Annie Guerin, Analysis Group, Inc., Montreal, Quebec, Canada; and Johannes Wolff and George Joseph, Novartis Pharmaceuticals Corp., East Hanover, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Wolff","sequence":"additional","affiliation":[{"name":"Ellen K. Ritchie, Cornell University and New York Presbyterian Hospital, New York, NY; Annie Guerin, Analysis Group, Inc., Montreal, Quebec, Canada; and Johannes Wolff and George Joseph, Novartis Pharmaceuticals Corp., East Hanover, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Joseph","sequence":"additional","affiliation":[{"name":"Ellen K. Ritchie, Cornell University and New York Presbyterian Hospital, New York, NY; Annie Guerin, Analysis Group, Inc., Montreal, Quebec, Canada; and Johannes Wolff and George Joseph, Novartis Pharmaceuticals Corp., East Hanover, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.4184"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2016.72.0011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T09:42:41Z","timestamp":1653817361000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2016.72.0011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,20]]},"references-count":1,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,5,20]]}},"alternative-id":["10.1200\/JCO.2016.72.0011"],"URL":"https:\/\/doi.org\/10.1200\/jco.2016.72.0011","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,20]]},"assertion":[{"value":"2017-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}